chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Small red rash on right inside arm last few hours soon after shot, Swelling, red, lump, hot to the touch itching  - gets bigger every day causes pain to radiate down left arm at times - reaction is still there on 5 around the jab site on the left arm= started around 11:00 PM on 03/25/2021;  103.7 fever started 03/25/2021 and last about 24 hours; finger extremely and hot and burning lasted about 48 hours.  Fingertips still feel like electricity is running through them and fingers/hands still hurt; extremely hungry/thirsty from 03/25/2021 - 03/29/2021; fatigue, pain at base of skull under ears, tinnitus extremely loud and both ears feel like ear ache; During the night of my high fever, lower back where kidneys are started hurting very badly.  What is still left of that pain on day 5 is a pain radiating from my lower back down my right leg many times throughout the day (treating with ibuphrophen).   Pain around knees, elbows, ankles, and bottom of feet- different than joint pain.  All my POTS symptoms are in high gear (tachycardias, very low BP,  pain, dizzy, vertigo).    If the leg/lower back pain, and left arm problems continue, I will see my neurologist or immunologist.  I have reached out to both to make them aware.  My husband had the JJ shot same day, same place and had zero side affects.
Information has been received from a nurse practitioner referring to 1 year old female patient with "murmur" and no known drug allergy. The patient had no illness at time of vaccination. The patient's birth weight was 7lb 9oz. Concomitant therapies included hepatitis A (unspecified) and (Oka/Merck) VARIVAX. On 22-APR-2016 at 11:26, the patient was vaccinated with (wistar ra 27-3) M-M-R II  lot # reported as L042818 dose 1, subcutaneously in the left thigh). The vaccine was properly stored at 53.2 F for 9 hours and 25 minutes. There were no previous temperature excursions. Digital data logger was involved. No adverse effect was reported. This is one of several reports received rom the same reporter. Additional information has been requested.
experience pain/stiffness; stiffness; This is a spontaneous report from a contactable other health professional and a consumer (patient). A 61-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number was not reported), via an unspecified route of administration on an unspecified date (at an unspecified age) at single dose for COVID-19 immunization; tofacitinib citrate (XELJANZ XR), orally from Jan2020 to an unspecified date, at 11 mg, daily for rheumatoid arthritis. The patient medical history included flare-up. The patient's concomitant medications were not reported. The patient held tofacitinib citrate 7 days post second Covid vaccine. Within 4 days of being off tofacitinib citrate he started to experience pain/stiffness. Flare-up pre existing precipitated switch to tofacitinib citrate. Flare up had improved in the last 6 weeks since tofacitinib citrate started to work. MD was aware. The action taken in response to the events tofacitinib citrate was post therapy. The outcome of the events was unknown.  No follow-up attempts are possible, information about batch/lot number cannot be obtained.
Redness, swelling, hot and firm to touch, upper left arm, area where Dtap was administered.
On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 23-Aug-22; No adverse event; The patient received dose after 30 day use date or after manufacturer date of expiry; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient received dose after 30 day use date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 23-Aug-22) and NO ADVERSE EVENT (No adverse event) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: COVID-19 vaccine (Unspecified COVID-19 vaccine Dose 1), COVID-19 vaccine (Unspecified COVID-19 vaccine Dose 3) and COVID-19 vaccine (Unspecified COVID-19 vaccine Dose 2). Past adverse reactions to the above products included No adverse event with COVID-19 vaccine, COVID-19 vaccine and COVID-19 vaccine.    On 23-Aug-2022 at 3:46 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 23-Aug-2022 at 3:46 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received dose after 30 day use date or after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 23-Aug-22) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient received dose after 30 day use date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 23-Aug-22) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (The patient received dose after 30 day use date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (On 18-Apr-2022 the vial was initially stored in the refrigerator and administered on 23-Aug-22).    No concomitant medications was reported.  On 18-Apr-2022 the vial was delivered and stored in the refrigerator on same date. The vial size is of 5.5mL. The vial did not undergo any temperature excursions. Vaccines were only offered from March-2022 forward to the patient. For each vaccine date, only removed one vial from the freezer to place in the refrigerator the day before it was used (each Monday, one vial was removed from the freezer and placed into the refrigerator).  No treatment drug details was reported.
SEVERE HEADACHE,WHEN L WAS TAKING A SHOWER AND MY RIGHT EYE MOVED TO RIGHT.
Upper arm red, warm, taut, tender 2 days after DTAP in L arm.  Omnicef 128 mg bid x 10d. Ibuprofen - warm moist soaks; sterile abscess. Recheck.
9 hrs. after injection, when I got into bed, my right leg started twitching uncontrollably for several hours and I had a fever of 100 degrees, next morning I went to urgent care. DO noT remember name of medication given.
15 minutes after administration of the vaccines, patient with sudden shortness of breath and choking sensation, complaint of itchy mouth. On exam with poor aeration of lungs, diffuse wheezing, retractions, tachypnea, hypoxia to 90% RA, tachycardia, profuse watery discharge from mouth and nose, periorbital and lower lip edema, followed by decreased level of consciousness.  Patient treated with albuterol and albuterol/ipratropium nebs, oral dexamethasone, IM epinephrine, cetirizine, and famotidine.  Symptoms fully resolved after these medications.  patient then transported to local emergency department via ambulance for further monitoring
14OCT97 pt recv vax;17OCT97 unable to move, very painful, sl fever used heating pad, APAP 22OCT97 unable to reach out still applying heat some fever found by RN;told to use cool compress APAP;
10/13/09 6PM client took FLUMIST intranasal tolerated this well. 610 PM client became pale and limp with eyes rolled upward. Was roused after 10 seconds and responded to verbal stimuli. 615 PM client became pale again and went limp (arms and legs) for 10 seconds then was roused again; responding to verbal stimuli. Was seen at hospital E.R. immediately after appt. at clinic 620PM. 10/13/09 620 PM client was seen at Medical Center Emergency Department, client was released after approx. 1 hour. Mom states client had no further "fainting" episodes that night, her color returned and appeared top be "okay" during the day of 10/14/09. 10/22/09 Received call from mom stating that pt was seen at a Pediatric clinic by doctor and has been diagnosed with pneumonia on 10/21/09 - client had a chest X Ray done at that M.D. visit. No hospitalization required. Client is home with parents.
A legal complaint was received from attorney alleging that 11 month old female child received a dose of Tri-Immunol vaccine on 1/24/97, at the age of 11 months, and subsequently "suffered an acute and severe reaction which resulted in log term damage." According to the legal complaint, as a result of her 1/24/97 DPT vaccination, the child is mentally retarded. The legal complaint alleges, "the pertussis component of the DPT vaccine was a producing cause of the damages." An immunization schedule, provided in the medical records indicated that the child received her first doses of DPT and Hemophilus influenzae type B on 5/15/96. The pt was born prematurily; gestational age was reported as 34-36 weeks. At birth, the child's Apgar scores were recorded at 7 after one minute, and 9 after five minutes. During delivery, the child experienced deceleration as a result of the "cord being wrapped around his neck." At age 14 months, the child bit into an electrical cord and experienced a shock which knocked her backwards and resulted in the loser of her bottom teeth. She also experienced a superficial burn and a "hole in her lip." She did not loose consciousness. She was subsequently hospitalized. Her hospital stay was uneventful. The child's mother reported that after the shock the child never again used previously known single vocabulary words. In April 1997, she had pressure equalizing tubes inserted into her ears for chronic otitis media. There are no known allergies, chronic illnesses, or documented toxic exposures. On 5/15/96, she received a dose of DPT. Additional suspected immunization included poliomyelitis vaccine, and DPT/ Hib vaccines, HIB, hep B, and poliomyelitis virus vaccine, live, oral. There were no chronic medications. According to medical records dated 1/28/98, a physician indicated that the pt exhibited characteristics of autism. On 1/7/98, an otolaryngologist confirmed that the pt's speech was performed, diagnoses of attention deficit hyperactivity disorder and speech delay were made. On 4/29/98, an examination by a pediatrician indicated that the child did not fit the criteria for an autistic disorder; however, did fit the criteria for pervasive developmental disorder. On 2/4/99, a psychological evaluation suggested that the pt meets the criteria for "pervasive developmental disorder, NOS." On 1/6/03, at six years of age, a psychiatric evaluation was performed; diagnoses of separation anxiety, elimination disorder, and encopresis with constipation were made. On 2/26/03, a sensory profile was performed; a diagnosis of autism/PDD was made. Medical records are on file.
REACTION TO 2ND DOSE OF MODERNA VACCCINE GIVEN ON 10/8/2021 @ 9:30AM, WOKE ON 10/9/2021 TO RIGHT ARMPIT SWELLING AND SORENESS ON SAME ARM AS THE INJECTION SITE, POSSIBLE LYMPH NODES SWELLING. HAVE BEEN TAKEN TYLENOL FOR PAIN REPORTED INJURY ON 10/11/2021 STILL HAVE SWELLING AND TENDERNESS UNDERARM PIT
Dizziness when moving (laying down and turning to sides) and getting out of bed or even  from sitting up right.  Fall to my back and side if sitting up from dizziness  or it was a struggle to walk few steps.  (feel like the sorrounding is  moving around .   It was worst on Saturday morning.  Took anti allergy at 12 noon on Saturday Feb 20, 2021.  Then felt gradually better.  Today Feb 22. 2021 still feeling dizzy need help to get out of bed to bathroom this morning.   Spells of dizziness comes and goes.
developed another rash this time the size of a soft ball with no itching, the rash look like varicose veins.; minor pain at site after about 3 hrs; swelling at site after about 3 hrs; This spontaneous case was reported by a consumer and describes the occurrence of RASH (developed another rash this time the size of a soft ball with no itching, the rash look like varicose veins.), VACCINATION SITE PAIN (minor pain at site after about 3 hrs) and VACCINATION SITE SWELLING (swelling at site after about 3 hrs) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Aching in knees and Stomachache. Concurrent medical conditions included Heart disorder. Concomitant products included METOPROLOL for Heart disorder, SACUBITRIL VALSARTAN SODIUM HYDRATE (ENTRESTO), LEVOTHYROXINE SODIUM (SYNTHROID), SPIRONOLACTONE (ALDACTONE A) and FAMOTIDINE (PEPCID AC) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (developed another rash this time the size of a soft ball with no itching, the rash look like varicose veins.), VACCINATION SITE PAIN (minor pain at site after about 3 hrs) and VACCINATION SITE SWELLING (swelling at site after about 3 hrs). At the time of the report, RASH (developed another rash this time the size of a soft ball with no itching, the rash look like varicose veins.), VACCINATION SITE PAIN (minor pain at site after about 3 hrs) and VACCINATION SITE SWELLING (swelling at site after about 3 hrs) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication information  was not provided  by the reporter. Medical history included Back , knees , stomach not specified.   This case was linked to MOD-2021-060863 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up document received on 15-JUL-2021 contains new information of event updated, outcome updated, medical history and  concomitant medication information updated
after her first dose of the Pfizer covid vaccine about 30 min later she felt nauseas and felt like she was going to pass out; after her first dose of the Pfizer covid vaccine about 30 min later she felt nauseas and felt like she was going to pass out; This is a spontaneous report from a contactable consumer (patient) from a Regulatory Authority. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported and expiry date: unknown), dose 1 via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patients's medical history and concomitant medications were not reported. The patient experienced after her first dose of the pfizer covid vaccine about 30 min later she felt nauseas and felt like she was going to pass out on an unspecified date. Outcome of the events was unknown.  No follow-up attempts are needed. No further information expected.
12 hours after receiving my second dose I became very ill.; skin hurt; I became to shiver uncontrollably and could not get warm enough; I developed a fever of 101.4; My muscles ache. Instead of feeling "sick"this was more painful than "ill".; it is difficult tosleep.; I'm in somuch discomfort; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 29Mar2021 at 12:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, sleep apnea and pre-diabetes. Concomitant medications included propranolol 120 mg (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN) and armodafinil (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Mar2021 at 15:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation and morphine on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Mar2021 at 00:30 after 12 hours of second dose, the patient experienced illness, skin hurt, shivered uncontrollably and was not getting warmed enough, fever - 101.4 (unspecified unit), muscle ache, hurt to move, discomfort and difficulty sleeping. The patient did not receive any treatment for the event. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of illness, skin pain, shivers, fever, muscle ache, sleep difficult and discomfort were not recovered.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Experienced COVID-like symptoms.  Headache, sweating, body aches for roughly 12-16 hours
GI discomfort; Loss of appetite; Dizzy; Fever; Body ache; Chills; This spontaneous case was reported by a pharmacist and describes the occurrence of ABDOMINAL DISCOMFORT (GI discomfort), DECREASED APPETITE (Loss of appetite), DIZZINESS (Dizzy), PYREXIA (Fever) and MYALGIA (Body ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027C21A and 044B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-May-2021, the patient experienced ABDOMINAL DISCOMFORT (GI discomfort), DECREASED APPETITE (Loss of appetite), DIZZINESS (Dizzy), PYREXIA (Fever), MYALGIA (Body ache) and CHILLS (Chills). On 19-May-2021, ABDOMINAL DISCOMFORT (GI discomfort), DECREASED APPETITE (Loss of appetite), DIZZINESS (Dizzy), PYREXIA (Fever), MYALGIA (Body ache) and CHILLS (Chills) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  No treatment information was provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Unknown if adverse event is related to vaccine. Received H1N1 mist on Oct 12; subsequently admitted on 11/1/09 with new onset diabetes mellitus, in DKA, mom states increase thirst, urination started after vaccine. Probable Type I. Mom is Type I diabetic herself. 11/20/09 Medical records received for dates 11/1/09 to 11/3/09. DX: vomiting, diabetes type 1, ketoacidosis, hyperpotassemia, dehydration. Presenting sx: repeated vomiting, thirst. Assessment: WNL. Pt admitted to ICU w/ elevated glucose levels. Pt. parent states sx began after H1N1 vax approx 2 wks ago. ICD9 codes: 707.03, 280.13, 276.7, 276.51, 314.01.
Prevnar 13 with particulates was given to some of the patients; Prevnar 13 with particulates was given to some of the patients; This is a spontaneous report from a contactable pharmacist. This pharmacist reported similar events for three patients. This is the third of three reports.   An 80-year-old female patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at single dose for immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) with particulates was given to the patient. Pharmacist reported that they have a box of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) shot and they have already given it to some of the patient. At the time of the reporting (11Jun2019), when the pharmacist was about to give one to a patient, it looked like there was a very big particulate and when the pharmacist look through the box, about 5 of the shots have that in there so the pharmacist took it out completely. Also stated that it was white and it was pretty big. It was like sand so the pharmacist left it out in the fridge and it kind of dissolve on the top of the shot. It looked like a big patch of knock on the side. It was also reported that the pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) was in the fridge and was monitored 24/7. Clarified that the product was not frozen at any time. Pharmacist reported lot number: X70865, Expiration date: Dec 2020, and NDC# 00005197102 but was not sure to which patient it was administered.  Information on lot number, batch number and expiration date has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2019256007 Same reporter, event, product/ different patient;US-PFIZER INC-2019255933 Same reporter, event, product/ different patient
Immediately following injection, patient vomited x 30 minutes. The following morning she had numbness in her lips. On the second day following the injection, she developed left axillary edema which has not resolved.
PATIENT HAD PFIZER COVID VACCINE, Dose 1 date:  01/6/2021, Dose 2 date:  01/27/2021, AND TESTED POSITIVE TO COVID.
30 minutes after receiving Trumemba patient felt pain at the injection site and also warm and hard. She also had swelling of her lips which lasted 10 minutes, in additions she reported a constant headache that responded to Advil but persisted for 36 hours.
Breakthrough case admission after three vaccines Moderna 4/23/21 Lot# 048B21A;  Moderna 5/21/21 Lot# 033C21A;  Moderna 3/9/22 Lot# 033K21-2A
The day after receiving vaccines, mom noticed hives on legs, arms, back, and bottom. Mom called back later in the day stating the hives were spreading and seemed much worse. Baby was also irritable throughout the day.
knot in the arm where the vaccine was given; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (knot in the arm where the vaccine was given) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced VACCINATION SITE SWELLING (knot in the arm where the vaccine was given). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE SWELLING (knot in the arm where the vaccine was given) outcome was unknown. Not Provided
Patient received the Fluzone HD on 08/15/2020 but did not report her adverse reaction until 09/03/2020. She reported she experienced involuntary shaking of the  immunized arm a couple of hours after she received her vaccine and it continued intermittently until she fell asleep. The next day when she awoke, the shaking had  resolved. She stated she was not concerned enough about the shaking to report it to the pharmacy. She reported it during her next trip to the pharmacy,
Received second Guardasil shot yesterday and complaining of nausea and sore throat today